Literature DB >> 30683244

Comparing comorbidity measures and fatigue post myocardial infarction.

Carolyn E Horne1, Sharona Johnson2, Patricia B Crane3.   

Abstract

PURPOSE/AIMS: The purpose of this study was to examine comorbidity measures that may relate to the symptom of fatigue post MI: self-reported comorbidities, medication-validated comorbidities, weighted comorbidities for fatigue, and number of comorbidities.
DESIGN: Using a cross sectional design, we interviewed a convenience sample of 98 adults, 65 and older, who were 6 to 8 months post myocardial infarction.
METHODS: Participants self-reported their comorbidities using a list of 23 comorbid conditions. All medications were visually inspected, and medications were reviewed by a geriatric pharmacist for a common side effect of fatigue. The Revised Piper Fatigue Scale was used to measure fatigue.
RESULTS: The mean age of the participants was 76 (SD = 6.3), and most of the sample were White (84%). Neither medication-validated comorbidities nor those medications with fatigue as a common side effect explained fatigue. When controlling for age, sex, and marital status, self-reported comorbidities explained 10% of the variance in fatigue (F (4, 93) = 2.65; p = 0.04). Having 5 or more self-reported comorbidities explained 7% of variance in fatigue scores (F (1, 96) = 7.53; p = 0.007).
CONCLUSION: Comorbidities are associated with fatigue post MI. Adults post MI with 5 or more comorbidities should be screened for fatigue.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbidities; Fatigue; Myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 30683244      PMCID: PMC6355153          DOI: 10.1016/j.apnr.2018.11.004

Source DB:  PubMed          Journal:  Appl Nurs Res        ISSN: 0897-1897            Impact factor:   2.257


  46 in total

1.  Cluster analysis of women's prodromal and acute myocardial infarction symptoms by race and other characteristics.

Authors:  Jean C McSweeney; Mario A Cleves; Weizhi Zhao; Leanne L Lefler; Shengping Yang
Journal:  J Cardiovasc Nurs       Date:  2010 Jul-Aug       Impact factor: 2.083

Review 2.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

3.  Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms.

Authors:  Jessina C McGregor; Peter W Kim; Eli N Perencevich; Douglas D Bradham; Jon P Furuno; Keith S Kaye; Jeffrey C Fink; Patricia Langenberg; Mary-Claire Roghmann; Anthony D Harris
Journal:  Am J Epidemiol       Date:  2005-03-01       Impact factor: 4.897

Review 4.  Methodology, design, and analytic techniques to address measurement of comorbid disease.

Authors:  Timothy L Lash; Vincent Mor; Darryl Wieland; Luigi Ferrucci; William Satariano; Rebecca A Silliman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-03       Impact factor: 6.053

5.  The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer.

Authors:  B F Piper; S L Dibble; M J Dodd; M C Weiss; R E Slaughter; S M Paul
Journal:  Oncol Nurs Forum       Date:  1998-05       Impact factor: 2.172

Review 6.  Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.

Authors:  Sara Roversi; Leonardo M Fabbri; Don D Sin; Nathaniel M Hawkins; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

7.  Cumulative illness rating scale.

Authors:  B S Linn; M W Linn; L Gurel
Journal:  J Am Geriatr Soc       Date:  1968-05       Impact factor: 5.562

8.  Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index.

Authors:  Anja Frei; Patrick Muggensturm; Nirupama Putcha; Lara Siebeling; Marco Zoller; Cynthia M Boyd; Gerben ter Riet; Milo A Puhan
Journal:  J Clin Epidemiol       Date:  2014-04-29       Impact factor: 6.437

9.  Charlson comorbidity index adjustment in intracerebral hemorrhage.

Authors:  Barak Bar; J Claude Hemphill
Journal:  Stroke       Date:  2011-07-28       Impact factor: 7.914

10.  Fatigue and Comorbidities in Multiple Sclerosis.

Authors:  Kirsten M Fiest; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kyla A McKay; Lindsay I Berrigan; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Mar-Apr
View more
  2 in total

1.  Factors Associated With Myocardial Infarction Reoccurrence.

Authors:  Willie M Abel; Lauren N Scanlan; Carolyn E Horne; Patricia B Crane
Journal:  J Cardiovasc Nurs       Date:  2021-02-28       Impact factor: 2.468

2.  Chronic Illness and Fatigue in Older Individuals: A Systematic Review.

Authors:  Maral Torossian; Cynthia S Jacelon
Journal:  Rehabil Nurs       Date:  2021 May-Jun 01       Impact factor: 1.625

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.